BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27650356)

  • 21. Long-Term Incidence and Predictors of Significant Hearing Loss Requiring Hearing Assistive Devices Among Childhood Cancer Survivors: A Population-Based Study.
    Beyea JA; Lau C; Cooke B; Hall S; Nathan PC; Gupta S
    J Clin Oncol; 2020 Aug; 38(23):2639-2646. PubMed ID: 32463737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St. Jude Lifetime Cohort Study.
    Brinkman TM; Bass JK; Li Z; Ness KK; Gajjar A; Pappo AS; Armstrong GT; Merchant TE; Srivastava DK; Robison LL; Hudson MM; Gurney JG
    Cancer; 2015 Nov; 121(22):4053-61. PubMed ID: 26287566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Audiological Monitoring in Children Treated with Platinum Chemotherapy.
    Fetoni AR; Ruggiero A; Lucidi D; De Corso E; Sergi B; Conti G; Paludetti G
    Audiol Neurootol; 2016; 21(4):203-211. PubMed ID: 27286730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology Group.
    Bass JK; Knight KR; Yock TI; Chang KW; Cipkala D; Grewal SS
    Pediatr Blood Cancer; 2016 Jul; 63(7):1152-62. PubMed ID: 26928933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hearing impairment after platinum-based chemotherapy in childhood.
    Einar-Jon E; Trausti O; Asgeir H; Christian M; Thomas W; Måns M; Jon K; Hannes P
    Pediatr Blood Cancer; 2011 Apr; 56(4):631-7. PubMed ID: 21298751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors.
    van Dijk IW; Cardous-Ubbink MC; van der Pal HJ; Heinen RC; van Leeuwen FE; Oldenburger F; van Os RM; Ronckers CM; Schouten-van Meeteren AY; Caron HN; Koning CC; Kremer LC
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):768-75. PubMed ID: 22954771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy.
    Cohen-Cutler S; Wong K; Mena V; Sianto K; Wright MA; Olch A; Orgel E
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1488-1495. PubMed ID: 33677052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
    Peleva E; Emami N; Alzahrani M; Bezdjian A; Gurberg J; Carret AS; Daniel SJ
    Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ototoxicity monitoring in children treated with platinum chemotherapy.
    Brooks B; Knight K
    Int J Audiol; 2018 Sep; 57(sup4):S34-S40. PubMed ID: 28737048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
    Chow EJ; Friedman DL; Yasui Y; Whitton JA; Stovall M; Robison LL; Sklar CA
    J Pediatr; 2007 Apr; 150(4):370-5, 375.e1. PubMed ID: 17382112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study.
    Whelan KF; Stratton K; Kawashima T; Waterbor JW; Castleberry RP; Stovall M; Sklar CA; Packer RJ; Mitby P; Aitken CL; Blatt J; Robison LL; Mertens AC
    Pediatr Blood Cancer; 2010 Jan; 54(1):103-9. PubMed ID: 19774634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns and predictors of clustered risky health behaviors among adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
    Lown EA; Hijiya N; Zhang N; Srivastava DK; Leisenring WM; Nathan PC; Castellino SM; Devine KA; Dilley K; Krull KR; Oeffinger KC; Hudson MM; Armstrong GT; Robison LL; Ness KK
    Cancer; 2016 Sep; 122(17):2747-56. PubMed ID: 27258389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperthyroidism After Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study.
    Inskip PD; Veiga LHS; Brenner AV; Sigurdson AJ; Ostroumova E; Chow EJ; Stovall M; Smith SA; Leisenring W; Robison LL; Armstrong GT; Sklar CA; Lubin JH
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):415-424. PubMed ID: 30769174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
    Fetoni AR; Brigato F; De Corso E; Lucidi D; Sergi B; Scarano E; Galli J; Ruggiero A
    Eur Arch Otorhinolaryngol; 2022 Oct; 279(10):4677-4686. PubMed ID: 35024956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overweight in childhood cancer survivors: the Swiss Childhood Cancer Survivor Study.
    Belle FN; Weiss A; Schindler M; Goutaki M; Bochud M; Zimmermann K; von der Weid N; Ammann RA; Kuehni CE
    Am J Clin Nutr; 2018 Jan; 107(1):3-11. PubMed ID: 29381792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term pulmonary disease among Swiss childhood cancer survivors.
    Kasteler R; Weiss A; Schindler M; Sommer G; Latzin P; von der Weid NX; Ammann RA; Kuehni CE;
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28868646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).
    Bhakta N; Liu Q; Ness KK; Baassiri M; Eissa H; Yeo F; Chemaitilly W; Ehrhardt MJ; Bass J; Bishop MW; Shelton K; Lu L; Huang S; Li Z; Caron E; Lanctot J; Howell C; Folse T; Joshi V; Green DM; Mulrooney DA; Armstrong GT; Krull KR; Brinkman TM; Khan RB; Srivastava DK; Hudson MM; Yasui Y; Robison LL
    Lancet; 2017 Dec; 390(10112):2569-2582. PubMed ID: 28890157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.
    Trendowski MR; Baedke JL; Sapkota Y; Travis LB; Zhang X; El Charif O; Wheeler HE; Leisenring WM; Robison LL; Hudson MM; Morton LM; Oeffinger KC; Howell RM; Armstrong GT; Bhatia S; Dolan ME
    Cancer; 2021 Nov; 127(21):4091-4102. PubMed ID: 34286861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol.
    Ilveskoski I; Saarinen UM; Wiklund T; Perkkiö M; Salmi TT; Lanning M; Mäkipernaa A; Pihko H
    Med Pediatr Oncol; 1996 Jul; 27(1):26-31. PubMed ID: 8614387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.